Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NITE
1551
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $6.51M | 0.01% |
256,563
+220,563
| +613% | +$3.9M |
|
|
CCI.PRA
1552
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $6.51M | 0.01% |
5,491
-3,083
| -36% | -$3.42M |
|
|
NAVG
1553
DELISTED
Navigators Group Inc
NAVG
| $6.49M | 0.01% |
92,893
+14,468
| +18% | +$1.01M |
|
1554
PUT
TG Therapeutics
TGTX
$8.48B
| $6.49M | 0.01% |
+807,100
| New | +$4.36M |
|
|
FFWM
1555
DELISTED
First Foundation Inc
FFWM
| $6.48M | 0.01% |
477,573
+142,743
| +43% | +$2.06M |
|
1556
Trupanion
TRUP
$1.4B
| $6.47M | 0.01% |
197,718
-86,314
| -30% | -$2.46M |
|
1557
iShares MSCI South Africa ETF
EZA
$602M
| $6.46M | 0.01% |
123,461
+86,040
| +230% | +$4.62M |
|
|
NXRT
1558
NexPoint Residential Trust
NXRT
$624M
| $6.46M | 0.01% |
168,424
+35,151
| +26% | +$1.29M |
|
1559
Trinity Industries
TRN
$2.36B
| $6.46M | 0.01% |
297,104
-30,534
| -9% | -$698K |
|
1560
PennyMac Financial
PFSI
$3.85B
| $6.45M | 0.01% |
+290,200
| New | +$6.36M |
|
1561
Unilever
UL
$140B
| $6.45M | 0.01% |
99,362
+41,756
| +72% | +$2.54M |
|
1562
PUT
WisdomTree India Earnings Fund ETF
EPI
$2.05B
| $6.45M | 0.01% |
+245,000
| New | +$6.01M |
|
|
XENT
1563
CALL
DELISTED
Intersect ENT, Inc
XENT
| $6.43M | 0.01% |
200,000
+115,000
| +135% | +$3.56M |
|
1564
Carlyle Secured Lending
CGBD
$785M
| $6.42M | 0.01% |
443,246
+184,407
| +71% | +$2.71M |
|
|
OSIR
1565
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $6.42M | 0.01% |
337,701
+304,385
| +914% | +$4.94M |
|
1566
CALL
eBay
EBAY
$47.2B
| $6.41M | 0.01% |
172,500
+162,500
| +1,625% | +$5.64M |
|
|
AVNS
1567
CALL
DELISTED
Avanos Medical
AVNS
| $6.4M | 0.01% |
150,000
+50,000
| +50% | +$2.24M |
|
|
QEP
1568
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $6.4M | 0.01% |
+821,700
| New | +$6.56M |
|
1569
EPAM Systems
EPAM
$5.77B
| $6.39M | 0.01% |
37,791
-106,373
| -74% | -$15.9M |
|
1570
Atara Biotherapeutics
ATRA
$98.8M
| $6.38M | 0.01% |
6,420
+5,919
| +1,181% | +$5.5M |
|
|
ESV
1571
DELISTED
Ensco Rowan plc
ESV
| $6.36M | 0.01% |
404,338
-472,238
| -54% | -$8.23M |
|
1572
Oaktree Specialty Lending
OCSL
$1.16B
| $6.34M | 0.01% |
408,051
-5,649
| -1% | -$84.2K |
|
1573
Rambus
RMBS
$9.75B
| $6.34M | 0.01% |
606,509
+206,056
| +51% | +$1.98M |
|
|
AKRX
1574
DELISTED
Akorn Inc
AKRX
| $6.34M | 0.01% |
1,800,667
-267,457
| -13% | -$1.03M |
|
1575
Accuray
ARAY
$31.8M
| $6.32M | 0.01% |
1,325,836
+68,568
| +5% | +$312K |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.